BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 20124048)

  • 21. A dual-labeled knottin peptide for PET and near-infrared fluorescence imaging of integrin expression in living subjects.
    Kimura RH; Miao Z; Cheng Z; Gambhir SS; Cochran JR
    Bioconjug Chem; 2010 Mar; 21(3):436-44. PubMed ID: 20131753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Specific targeting of human integrin α(v)β (3) with (111)In-labeled Abegrin™ in nude mouse models.
    Liu Z; Jia B; Zhao H; Chen X; Wang F
    Mol Imaging Biol; 2011 Feb; 13(1):112-20. PubMed ID: 20383594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 64Cu-Labeled Divalent Cystine Knot Peptide for Imaging Carotid Atherosclerotic Plaques.
    Jiang L; Tu Y; Kimura RH; Habte F; Chen H; Cheng K; Shi H; Gambhir SS; Cheng Z
    J Nucl Med; 2015 Jun; 56(6):939-44. PubMed ID: 25908832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model.
    Janssen ML; Oyen WJ; Dijkgraaf I; Massuger LF; Frielink C; Edwards DS; Rajopadhye M; Boonstra H; Corstens FH; Boerman OC
    Cancer Res; 2002 Nov; 62(21):6146-51. PubMed ID: 12414640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro and in vivo characterization of 64Cu-labeled Abegrin, a humanized monoclonal antibody against integrin alpha v beta 3.
    Cai W; Wu Y; Chen K; Cao Q; Tice DA; Chen X
    Cancer Res; 2006 Oct; 66(19):9673-81. PubMed ID: 17018625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 111In-labeled galectin-3-targeting peptide as a SPECT agent for imaging breast tumors.
    Kumar SR; Deutscher SL
    J Nucl Med; 2008 May; 49(5):796-803. PubMed ID: 18413389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. (64)Cu labeled AmBaSar-RGD2 for micro-PET imaging of integrin αvβ3 expression.
    Cai H; Li Z; Huang CW; Park R; Conti PS
    Curr Radiopharm; 2011 Jan; 4(1):68-74. PubMed ID: 22191616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Noninvasive visualization and quantification of tumor αVβ3 integrin expression using a novel positron emission tomography probe, 64Cu-cyclam-RAFT-c(-RGDfK-)4.
    Jin ZH; Furukawa T; Galibert M; Boturyn D; Coll JL; Fukumura T; Saga T; Dumy P; Fujibayashi Y
    Nucl Med Biol; 2011 May; 38(4):529-40. PubMed ID: 21531290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of two novel ⁶⁴Cu-labeled RGD peptide radiotracers for enhanced PET imaging of tumor integrin αvβ₃.
    Hernandez R; Czerwinski A; Chakravarty R; Graves SA; Yang Y; England CG; Nickles RJ; Valenzuela F; Cai W
    Eur J Nucl Med Mol Imaging; 2015 Nov; 42(12):1859-68. PubMed ID: 26016906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An engineered knottin peptide labeled with 18F for PET imaging of integrin expression.
    Miao Z; Ren G; Liu H; Kimura RH; Jiang L; Cochran JR; Gambhir SS; Cheng Z
    Bioconjug Chem; 2009 Dec; 20(12):2342-7. PubMed ID: 19908826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of 64Cu- and 125I-radiolabeled bitistatin as potential agents for targeting alpha v beta 3 integrins in tumor angiogenesis.
    McQuade P; Knight LC; Welch MJ
    Bioconjug Chem; 2004; 15(5):988-96. PubMed ID: 15366951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroPET imaging of integrin αvβ3 expressing tumors using 89Zr-RGD peptides.
    Jacobson O; Zhu L; Niu G; Weiss ID; Szajek LP; Ma Y; Sun X; Yan Y; Kiesewetter DO; Liu S; Chen X
    Mol Imaging Biol; 2011 Dec; 13(6):1224-33. PubMed ID: 21161690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and evaluation of 64Cu-labeled monomeric and dimeric NGR peptides for MicroPET imaging of CD13 receptor expression.
    Chen K; Ma W; Li G; Wang J; Yang W; Yap LP; Hughes LD; Park R; Conti PS
    Mol Pharm; 2013 Jan; 10(1):417-27. PubMed ID: 23190134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cystine-knot peptides engineered with specificities for α(IIb)β(3) or α(IIb)β(3) and α(v)β(3) integrins are potent inhibitors of platelet aggregation.
    Silverman AP; Kariolis MS; Cochran JR
    J Mol Recognit; 2011; 24(1):127-35. PubMed ID: 21194123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. (44)Sc: an attractive isotope for peptide-based PET imaging.
    Hernandez R; Valdovinos HF; Yang Y; Chakravarty R; Hong H; Barnhart TE; Cai W
    Mol Pharm; 2014 Aug; 11(8):2954-61. PubMed ID: 25054618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 99mTc-labeled cystine knot peptide targeting integrin αvβ6 for tumor SPECT imaging.
    Zhu X; Li J; Hong Y; Kimura RH; Ma X; Liu H; Qin C; Hu X; Hayes TR; Benny P; Gambhir SS; Cheng Z
    Mol Pharm; 2014 Apr; 11(4):1208-17. PubMed ID: 24524409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel
    Lucente E; Liu H; Liu Y; Hu X; Lacivita E; Leopoldo M; Cheng Z
    Bioconjug Chem; 2018 May; 29(5):1595-1604. PubMed ID: 29587479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A heterodimeric [RGD-Glu-[(64)Cu-NO2A]-6-Ahx-RM2] αvβ3/GRPr-targeting antagonist radiotracer for PET imaging of prostate tumors.
    Durkan K; Jiang Z; Rold TL; Sieckman GL; Hoffman TJ; Bandari RP; Szczodroski AF; Liu L; Miao Y; Reynolds TS; Smith CJ
    Nucl Med Biol; 2014 Feb; 41(2):133-9. PubMed ID: 24480266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo small-animal PET/CT of EphB4 receptors using 64Cu-labeled peptide.
    Xiong C; Huang M; Zhang R; Song S; Lu W; Flores L; Gelovani J; Li C
    J Nucl Med; 2011 Feb; 52(2):241-8. PubMed ID: 21233177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiolabeled high affinity peptidomimetic antagonist selectively targets alpha(v)beta(3) receptor-positive tumor in mice.
    Jang BS; Lim E; Hee Park S; Shin IS; Danthi SN; Hwang IS; Le N; Yu S; Xie J; Li KC; Carrasquillo JA; Paik CH
    Nucl Med Biol; 2007 May; 34(4):363-70. PubMed ID: 17499725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.